Article

Silhouette marks 20th NASA mission

Green Island, NY-Silhouette Optical Ltd. once again has trekked into the final frontier, marking the 20th space mission that included its eyewear products.

Green Island, NY-Silhouette Optical Ltd. once again has trekked into the final frontier, marking the 20th space mission that included its eyewear products.

On Dec. 9, a seven-member crew aboard the National Aeronautics and Space Administration (NASA) space shuttle Discovery was launched into space on a 12-day mission, designated STS-116, to the International Space Station. The astronauts each took sunwear and ophthalmic eyewear, including Silhouette's Titan Minimal Art, Titan Next Generation, and Adidas models.

Missions in space create new challenges for eyewear. For example, on space walks, astronauts wear hermetically sealed suits and cannot adjust their glasses for up to 10 hours at a time.

Silhouette and Adidas eyewear also provided sun protection for the mission, crucial in space, where the sun's rays are more than 30% stronger. In 2002, Silhouette worked with NASA to develop a lens with a thin gold coating and 5.5% light transmission. The lens design itself also protects the crew; its curved form further cuts the amount of light coming from the sides and vertically

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.